South Africa 'witnessing first steps of AIDS-free generation'

In this Business Day opinion piece, Donald Gips, the U.S. ambassador to South Africa, examines progress made in the country's fight against HIV/AIDS, writing that, through the coordination of governments, civil society, nongovernmental organizations (NGOs), educational institutions, and researchers from around the world, "we now have the tools that allow us for the first time to set the goal of achieving an AIDS-free generation -- when virtually no children are born with the virus; we have effective and comprehensive education and prevention strategies that help to reduce risk; and those who are infected with HIV have access to treatment that helps prevent them from developing AIDS and transmitting the virus."

Gips highlights progress made in the country with the help of PEPFAR and the U.S. Global Health Initiative and notes, "Today, [South Africa] has prioritized the transitioning of ownership of the full HIV/AIDS national response to the government, including treatment and care of HIV-infected and affected patients." He concludes, "Together, and driven by South African leadership, we are making huge strides across the prevention, education, treatment and care spectrum. ... We are witnessing the first step of an AIDS-free generation, happening here, now, in [South Africa]" (11/30).


http://www.kaiserhealthnews.orgThis article was reprinted from kaiserhealthnews.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Semaglutide reduced mortality in obese patients by lowering infection-related deaths during COVID-19 pandemic